Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Differentiated thyroid cancer is the most frequent type of thyroid cancer with an increasing
incidence in the last decades. The initial management is represented by surgical treatment …

Simple Summary Differentiated thyroid carcinoma (DTC) is characterized by an excellent
prognosis, with the exception of cases that develop in metastatic forms. Although I-131 has …

For patients undergoing radioiodine therapy (RIT) of differentiated thyroid carcinoma (DTC),
thyroid-stimulating hormone (TSH) stimulation prior to RIT can be achieved using thyroid …

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis,
risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in …

Molecular imaging is pivotal in evaluating and managing patients with different thyroid
cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully …

Background/Objectives: The management of differentiated thyroid cancer (DTC) patients has
undergone a major paradigm shift in past years, especially regarding the role of a careful …

Introduction Radioactive iodine (RAI) is commonly used in the management of differentiated
thyroid cancers (DTCs). However, the long-term efficacy and the risk of tumor recurrence …

Thyroid cancer, one of the most common endocrine tumors, generally has a favorable
prognosis but remains a significant medical and societal concern due to its high incidence …

Radioactive iodine (RAI) therapy can effectively eliminate persistent or recurrent disease in
patients with advanced differentiated thyroid cancer (DTC), potentially improving …